ASX Announcement 21 October 2026 Update on Commercial Terms for the Proposed Merger with Microba Life Sciences • Genetic Signatures Limited (ASX: GSS) (GSS) and Microba Life Sciences Limited (ASX: MAP) (Microba) have agreed, in principle, to revised terms for the proposed merger, under which...
Update on Commercial Terms for Proposed Merger with MAP
Filed with ASX ·
Watch Genetic Signatures' latest callGenetic Signatures (ASX:GSS) Q4 2026 Earnings Call · Replay · Aug 25Read the transcript of Genetic Signatures (ASX:GSS) Q4 2026 Earnings Call6ix is reading this filing.
Genetic Signatures Ltd. on 6ix
Story so far
Earlier from Genetic Signatures
- Response to Media Speculation & BCAL letter to GSS
- GSS: Response to Media Speculation & BCAL letter to GSS
- Quarterly Activities/Appendix 4C Cash Flow Report
- GSS Investor Presentation - Proposed Merger with MAP
- Receipt of Section 249D Notice from BCAL Diagnostics
Later from Genetic Signatures
All Genetic Signatures news releasesFollow Genetic Signatures into a list and get an email when it puts out news.
Follow Genetic Signatures